In February 2021 Tavistock helped make history as PR advisor to MGC Pharmaceuticals, the first medicinal cannabis company to IPO on the London Stock Exchange, which raised £6.5m in the process.

MGC Pharma is a European based bio-pharma company developing and supplying affordable standardised phyto-medicines to patients globally. It’s research and treatments are focused on using phytomedicines in three core areas: Neurology, Oncology, and Autoimmune diseases – including ArtemiC™ for treatment of Covid-19 infected patients.